Mitchell Levine

Mitchell Levine

Chairman en IMMUNOPRECISE ANTIBODIES LTD. .

Fortuna: 30 400 $ al 31/03/2024

Finance
Health Technology
Consumer Services

Perfil

Mitchell Stuart Levine is the founder of Enable Global Capital LLC, which was founded in 2002.
He held the title of Managing Member & Chief Compliance Officer at Enable Global Capital LLC from 2011 to 2017.
Mr. Levine is currently the Chairman & Chief Executive Officer at Smart Health Diagnostics Co. since 2022 and the Chairman at ImmunoPrecise Antibodies Ltd.
since 2023.
Mr. Levine has held former positions as Principal at Bear, Stearns & Co., Inc., Principal at Lehman Brothers Distressed Structured Credit Capital Partners, Principal at The Shemano Group, Inc., Managing Partner at Cove Capital Advisors, Inc., and Chief Financial Officer at OncoCyte Corp.
from 2017 to 2022.
Mr. Levine obtained his undergraduate degree from the University of California, Davis.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
21/03/2024 20 000 ( 0.08% ) 30 400 $ 31/03/2024

Cargos activos de Mitchell Levine

EmpresasCargoInicio
IMMUNOPRECISE ANTIBODIES LTD. Chairman 27/11/2023
Chief Executive Officer 01/11/2022
Todos los cargos activos de Mitchell Levine

Antiguos cargos conocidos de Mitchell Levine.

EmpresasCargoFin
Founder 01/01/2017
Cove Capital Advisors, Inc. Corporate Officer/Principal -
ONCOCYTE CORPORATION Director of Finance/CFO 01/06/2022
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Mitchell Levine.

Formación de Mitchell Levine.

University of California, Davis Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mitchell Levine.

Relaciones

18

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Empresas privadas6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

Ver las conexiones de la empresa